Somira Health review
Somira Health is a telehealth GLP-1 provider that transparently discloses both true monthly and discounted quarterly-prepay pricing side by side for compounded semaglutide ($189.99/mo or $136.66/mo quarterly) and tirzepatide ($239.99/mo or $193.33/mo quarterly).
- Semaglutide
- $189/mo (compounded)
- Tirzepatide
- $239/mo (compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
Semaglutide · modeled / year
$2,268
Tirzepatide · modeled / year
$2,868
Pricing verified August 2026
The Index scorecard
Somira Health scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Both monthly and quarterly prices disclosed together -- no disguised 'starting at' prepay trick
- Four named, checkable compounding pharmacy partners across four states
- Serves all 50 states
- Prices include supplies (wipes, syringes) and overnight shipping
The tradeoffs
- No medical director named on reachable pages
- True monthly (non-prepay) price is noticeably higher than the quoted quarterly rate
- LegitScript claim not independently re-verified via LegitScript's own database
- Some state-specific appointment requirements may add friction
The bottom line
Best for: Shoppers who want clear, honest side-by-side monthly-vs-quarterly pricing without a hidden prepay trap. Somira Health is a telehealth GLP-1 provider that transparently discloses both true monthly and discounted quarterly-prepay pricing side by side for compounded semaglutide ($189.99/mo or $136.66/mo quarterly) and tirzepatide ($239.99/mo or $193.33/mo quarterly).
Ranked #312 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Somira Health.
- #275Nirwana Health— Nirwana Health prescribes compounded semaglutide and tirzepatide with a confusing multi-tier pricing structure -- a '1-month/Introductory' rate marketed as both a promo AND 'best value,' undercut by cheaper prepaid 3- and 6-month plans.59/100
- #276Potere Health MD— Potere Health MD is a Utah-based, physician-led weight loss clinic offering semaglutide and tirzepatide in both FDA-approved and compounded forms via telehealth and in-person visits.59/100
- #277TeleCareSpot— TeleCareSpot is a telehealth weight-loss platform offering physician evaluations for compounded semaglutide, compounded tirzepatide, oral tirzepatide, and phentermine, with LegitScript verification displayed on-site.59/100
- #278Telos Rx— Publishes one complete price ladder — oral tirzepatide, first month and standing rate side by side — and quotes every injectable only after an intake, so the $99 and $139 on its cards are floors nobody can hold it to.56/100
- #279Hers— Hers (Hims & Hers Health, NYSE: HIMS) now sells only FDA-approved branded GLP-1 medications for weight loss — Wegovy, Zepbound, Ozempic, Mounjaro, and the new orforglipron pill 'Foundayo' — rather than compounded semaglutide.58/100
- #280MaxLife— MaxLife is a small, Kansas-based telehealth weight-loss provider whose only public pricing is a time-limited '$169 new client special' bundled with a 'First Week Free' hook -- a clear promotional rate rather than a stated standing price.58/100
The 24 programs nearest this one
- #313 TeleHealth Weight Solutions57
- #314 Vitalex Health57
- #315 Tablet Health57
- #316 Alinwell57
- #317 Magnolia Regenerative Medicine57
- #318 Luvo Health54
- #319 WellMedr54
- #320 ARSYNL Rx56
- #321 Aurelius Health Group56
- #322 ElleS56
- #323 GoodRx56
- #324 HelloWellness56
- #325 Injectco56
- #326 Luci56
- #327 Luma Meds56
- #328 Lumen Meds56
- #329 Marek Health56
- #330 Mochi Health56
- #331 Rex MD56
- #332 Vita Bella56
- #333 ZYP Medical56
- #334 Mint Med55
- #335 Premium Health55
- #336 Call-On-Doc55
Pricing, states and verification reflect Somira Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Somira Health's site. Not medical advice; see our disclosure.